Return to Article Details
TNFRSF1B-DRIVEN MYELOID PLASTICITY CONSTITUTES A CLINICALLY TRACTABLE IMMUNOSUPPRESSIVE AXIS ACROSS HUMAN CANCERS
Download
Download PDF